#tumorcells — Public Fediverse posts

Boostimmune Secures Japanese Patent for Sequence-Independent TCTP Antibody Technology Targeting MDSC Accumulation

Japanese patent granted for technology that inhibits TCTP released from dead tumor cells using antibodies to suppress the…
#EuropeSays #Japan #JP #Accumulation #IntellectualProperty #Japanese #Japanesepatent #TadatsuguTaniguchi #TCTP #therapeuticcompositions #tumorcells #tumormicroenvironment
https://www.europesays.com/japan/57757/

Seed Funding to Advance Biopsy Catchment Technology and Liquid Specimen Biorepository

Virchow Medical has closed a $4 million seed financing round led by Cerberus Vent…
#UnitedStates #US #USA #america #Biopsy #clinicallaboratory #diagnosticinnovation #genomicsequencing #LiquidBiopsy #medicaltechnology #moleculardiagnostics #oncology #pilotprograms #PrecisionMedicine #science #specimenbiorepository #technology #tumorcells #unitedstatesofamerica #venturecapital
https://www.europesays.com/2926335/

A 13-year-old boy has become the first person to be cured of this deadly brain cancer

https://web.brid.gy/r/https://www.upworthy.com/first-person-cured-of-dipg-ex1/?utm_source=rss&utm_medium=rss&utm_campaign=first-person-cured-of-dipg-ex1

A 13-year-old boy has become the first person to be cured of this deadly brain cancer

https://web.brid.gy/r/https://www.upworthy.com/first-person-cured-of-dipg-ex1/?utm_source=rss&utm_medium=rss&utm_campaign=first-person-cured-of-dipg-ex1

A 13-year-old boy has become the first person to be cured of this deadly brain cancer

https://web.brid.gy/r/https://www.upworthy.com/first-person-cured-of-dipg-ex1/?utm_source=rss&utm_medium=rss&utm_campaign=first-person-cured-of-dipg-ex1

Can a groundbreaking cancer therapy help people with multiple sclerosis?

Grace Miller at a follow-up visit at the Cleveland Clinic nine months after she underwent an experimental CAR-T…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #Cancertherapy #CentralNervousSystem #ClevelandClinic #GraceMiller #Health #immunecells #MartyCarrick #MultipleSclerosis #tumorcells
https://www.newsbeep.com/us/525662/

This Badass Creature Has the Power to Kill Brain Tumors—and Scientists Found a Way to Use It

Time and again, the adrenaline-inducing show Fear Factor brought out scorpions to scare contestants. As the arachnids crept…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Wildlife #braintumors #cancer #CancerResearch #chlorotoxin #CityofHope #Researchers #Science #ScienceTranslationalMedicine #scorpions #snakevenom #treatmentmethod #tumorcells
https://www.newsbeep.com/us/184656/

DATE: September 13, 2024 at 08:00AM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

Focusing on tumor cells brings insights into cancer neuroscience

https://t.co/lQlP9PUd2P

#medtech #neuroscience #tumorcells

Here are any URLs found in the article text:

https://t.co/lQlP9PUd2P

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: September 13, 2024 at 08:00AM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

Focusing on tumor cells brings insights into cancer neuroscience

https://t.co/lQlP9PUd2P

#medtech #neuroscience #tumorcells

Here are any URLs found in the article text:

https://t.co/lQlP9PUd2P

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: September 13, 2024 at 08:00AM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

Focusing on tumor cells brings insights into cancer neuroscience

https://t.co/lQlP9PUd2P

#medtech #neuroscience #tumorcells

Here are any URLs found in the article text:

https://t.co/lQlP9PUd2P

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: September 12, 2024 at 06:00PM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

Focusing on tumor cells brings insights into cancer neuroscience

https://t.co/lQlP9PUd2P

#medtech #neuroscience #tumorcells

Here are any URLs found in the article text:

https://t.co/lQlP9PUd2P

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: September 12, 2024 at 06:00PM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

Focusing on tumor cells brings insights into cancer neuroscience

https://t.co/lQlP9PUd2P

#medtech #neuroscience #tumorcells

Here are any URLs found in the article text:

https://t.co/lQlP9PUd2P

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: September 12, 2024 at 06:00PM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

Focusing on tumor cells brings insights into cancer neuroscience

https://t.co/lQlP9PUd2P

#medtech #neuroscience #tumorcells

Here are any URLs found in the article text:

https://t.co/lQlP9PUd2P

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

Challenge #159: Choosing the best #CancerTherapy.

#GeneticTests promise targeted #cancer therapies, yet the effectiveness of drugs differs from patient to patient. Researchers at #mdcBerlin are analyzing the #proteins in #TumorCells.

More: https://www.helmholtz.de/en/research/helmholtz-challenges/challenge/choosing-the-best-cancer-therapy/#InspiredByChallenges @helmholtz_en

Challenge #159: Choosing the best #CancerTherapy.

#GeneticTests promise targeted #cancer therapies, yet the effectiveness of drugs differs from patient to patient. Researchers at #mdcBerlin are analyzing the #proteins in #TumorCells.

More: https://www.helmholtz.de/en/research/helmholtz-challenges/challenge/choosing-the-best-cancer-therapy/#InspiredByChallenges @helmholtz_en

Challenge #159: Choosing the best #CancerTherapy.

#GeneticTests promise targeted #cancer therapies, yet the effectiveness of drugs differs from patient to patient. Researchers at #mdcBerlin are analyzing the #proteins in #TumorCells.

More: https://www.helmholtz.de/en/research/helmholtz-challenges/challenge/choosing-the-best-cancer-therapy/#InspiredByChallenges @helmholtz_en

Challenge #159: Choosing the best #CancerTherapy.

#GeneticTests promise targeted #cancer therapies, yet the effectiveness of drugs differs from patient to patient. Researchers at #mdcBerlin are analyzing the #proteins in #TumorCells.

More: https://www.helmholtz.de/en/research/helmholtz-challenges/challenge/choosing-the-best-cancer-therapy/#InspiredByChallenges @helmholtz_en